Epsilon M&A Deal Report - Centre Azuréen de Cancérologie (CAC)
Transaction Multiples for the Valuation of Private Companies
Private Group led by Andera Acto / Centre Azuréen de Cancérologie (CAC)
No EMAT :
120397
Announced Date :
23/12/2024
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Andera Acto
Target :
Centre Azuréen de Cancérologie (CAC)
Country :
France
Sector of activity :
- Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Clinics and hospitals
Business Description :
The Centre Azuréen de Cancérologie specializes in oncology and radiotherapy. > Offers comprehensive care for cancer patients, collaborating with both public and private regional healthcare...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns | ns | ||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Clinics and hospitals » = 126
| Date | Acquirer | Target | Country | Multiples | See details |
| 04/02/2025 | Fagron | Guinama | Spain | ** | 120373 |
| 18/09/2019 | Cousin Medical Group (CMG) | France Rachis Distribution Et Développement (FR2D) | France | ** | 120188 |
Source: Epsilon Research / EMAT
